- Home
- CIF vs SLGL Comparison
CIF vs SLGL Comparison
Compare CIF & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIF
- SLGL
- Stock Information
- Founded
- CIF 1988
- SLGL 1997
- Country
- CIF United States
- SLGL Israel
- Employees
- CIF N/A
- SLGL N/A
- Industry
- CIF Trusts Except Educational Religious and Charitable
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- CIF Finance
- SLGL Health Care
- Exchange
- CIF Nasdaq
- SLGL Nasdaq
- Market Cap
- CIF 31.0M
- SLGL 17.0M
- IPO Year
- CIF N/A
- SLGL 2018
- Fundamental
- Price
- CIF $1.69
- SLGL $0.62
- Analyst Decision
- CIF
- SLGL Strong Buy
- Analyst Count
- CIF 0
- SLGL 2
- Target Price
- CIF N/A
- SLGL $5.00
- AVG Volume (30 Days)
- CIF 43.9K
- SLGL 44.1K
- Earning Date
- CIF 01-01-0001
- SLGL 03-21-2025
- Dividend Yield
- CIF 10.11%
- SLGL N/A
- EPS Growth
- CIF N/A
- SLGL N/A
- EPS
- CIF N/A
- SLGL N/A
- Revenue
- CIF N/A
- SLGL $11,707,000.00
- Revenue This Year
- CIF N/A
- SLGL $772.97
- Revenue Next Year
- CIF N/A
- SLGL N/A
- P/E Ratio
- CIF N/A
- SLGL N/A
- Revenue Growth
- CIF N/A
- SLGL 869.93
- 52 Week Low
- CIF $1.47
- SLGL $0.33
- 52 Week High
- CIF $1.77
- SLGL $1.65
- Technical
- Relative Strength Index (RSI)
- CIF 36.37
- SLGL 43.15
- Support Level
- CIF $1.71
- SLGL $0.55
- Resistance Level
- CIF $1.76
- SLGL $0.70
- Average True Range (ATR)
- CIF 0.02
- SLGL 0.07
- MACD
- CIF -0.00
- SLGL 0.01
- Stochastic Oscillator
- CIF 16.67
- SLGL 37.15
About CIF MFS Intermediate High Income Fund
Mfs Intermediate High Income Fund is a United States based diversified closed-end management investment company. Its investment objective is to seek high current income but may also consider capital appreciation. The fund invests a majority of its net assets, including borrowings for investment purposes, in high-income debt instruments. Its portfolio of investments includes investment grade corporate bonds, government securities and other securities.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.